<DOC>
	<DOCNO>NCT01085877</DOCNO>
	<brief_summary>This trial conduct Europe . The aim trial compare absorption estradiol single dose two 25 mcg estradiol vaginal tablet , produce two different production site , postmenopausal woman atrophic vaginitis .</brief_summary>
	<brief_title>Comparison Two Vaginal Tablets , Produced Different Sites , Postmenopausal Women With Atrophic Vaginitis</brief_title>
	<detailed_description />
	<mesh_term>Atrophy</mesh_term>
	<mesh_term>Estradiol</mesh_term>
	<mesh_term>Polyestradiol phosphate</mesh_term>
	<mesh_term>Estradiol 3-benzoate</mesh_term>
	<mesh_term>Estradiol 17 beta-cypionate</mesh_term>
	<mesh_term>Estradiol valerate</mesh_term>
	<criteria>Subjects able use German language , speak write Postmenopausal woman : 5 year last menstruation ; ovary surgically remove 2 year prior trial start Availability normal mammogram within 1 year prior trial start Good general health No significant illness could interfere subject 's participation trial , base judgment physician Known suspect allergy estradiol related product Known , suspect past history breast cancer Abnormal genital bleed Previous oestrogen and/or progestin hormone replacement therapy Use type vaginal vulvar preparation , e.g . pessary , contraceptive sponge , douche , vaginal moisturizers , nonoestrogenic medication include KY jelly etc. , 1 month prior first plan drug administration Hot flush require systemic hormone replacement treatment Known insulin dependent noninsulin dependent diabetes mellitus Systolic blood pressure ( BP ) 160 mm Hg and/or diastolic BP 100 mm Hg , currently treat untreated Active deep venous thrombosis thromboembolic disorder history condition Active arterial thrombosis document history condition Known suspect liver and/or kidney impairment base medical history , physical examination , and/or laboratory result Known HIV infection base laboratory result Porphyria Body Mass Index ( BMI ) 30.0 kg/m2 Cervical smear present PAP class II Known suspect vaginal infection require treatment Known alcohol drug abuse , heavy smoking ( 20 cigarette day ) Currently use steroid hormone ( except topical inhalation glucocorticoid preparation ) drug know significantly influence oestrogen metabolism barbiturate , phenytoin , rifampicin , carbamazepine Subject participate trial involve investigational product within last 30 day prior first plan drug administration</criteria>
	<gender>Female</gender>
	<minimum_age>55 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>June 2014</verification_date>
</DOC>